Myomo (NYSEAMERICAN:MYO) Director Buys $39,494.91 in Stock

Posted by Brian Himes on May 18th, 2026

Myomo, Inc. (NYSEAMERICAN:MYO – Get Free Report) Director Thomas Kirk bought 43,401 shares of the firm’s stock in a transaction on Monday, May 18th. The stock was purchased at an average price of $0.91 per share, with a total value of $39,494.91. Following the completion of the acquisition, the director owned 628,863 shares of the company’s stock, valued at approximately $572,265.33. This trade represents a 7.41% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Myomo Stock Down 7.8%

Shares of NYSEAMERICAN MYO traded down $0.07 during mid-day trading on Monday, reaching $0.84. The company had a trading volume of 430,602 shares, compared to its average volume of 350,290. The stock has a fifty day moving average of $0.76 and a two-hundred day moving average of $0.84. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.36 and a current ratio of 2.73. The company has a market capitalization of $32.42 million, a price-to-earnings ratio of -2.33 and a beta of 1.39. Myomo, Inc. has a 12-month low of $0.61 and a 12-month high of $3.45.

Hedge Funds Weigh In On Myomo

Several institutional investors have recently added to or reduced their stakes in MYO. Cubist Systematic Strategies LLC lifted its stake in Myomo by 157.4% in the first quarter. Cubist Systematic Strategies LLC now owns 49,101 shares of the company’s stock valued at $236,000 after buying an additional 30,028 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of Myomo during the first quarter worth approximately $75,000. Jane Street Group LLC grew its holdings in Myomo by 84.2% during the first quarter. Jane Street Group LLC now owns 162,658 shares of the company’s stock worth $782,000 after buying an additional 74,338 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Myomo during the first quarter worth $114,000. Finally, Geode Capital Management LLC grew its holdings in Myomo by 160.8% during the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock worth $1,446,000 after buying an additional 412,631 shares in the last quarter. 44.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Craig Hallum reaffirmed a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $7.67.

Read Our Latest Stock Report on Myomo

Myomo Company Profile

(Get Free Report)

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.